The interactions between sex hormones, excessive aromatase activity in adipose tissue, hormone production by fat cells, and the presence of inflammatory markers occurring in the course of obesity lead to reduced testosterone production and thus contribute to hypogonadism [113]. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.